Pharmaresearch Q2 Operating Profit Forecast at 70B KRW, Up 25.3%; Medical Device Exports Rise 35.5%
According to Samsung Securities, Pharmaresearch forecasts Q2 operating profit at 70 billion KRW, up 25.3% year-over-year, with revenue reaching 172.5 billion KRW (up 22.6%). The company is accelerating overseas expansion through medical tourism growth and export channels in Japan, Europe, and the
PharmaResearch+3.96%
GateNews·07-17 08:19
